BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11817606)

  • 1. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al.
    Hmida Y; Schmit P; Gilson G; Humbel RL
    Arthritis Rheum; 2002 Jan; 46(1):280-2. PubMed ID: 11817606
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antinuclear antibody profile in progressive systemic sclerosis. A multicenter study].
    Martínez-Cordero E; Burgos-Vargas R; Herrera-Esparza R; Reyes PA
    Rev Invest Clin; 1983; 35(4):273-7. PubMed ID: 6369466
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z; Piette JC
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antinuclear antibodies in patients with systemic scleroderma].
    Wranicz A; Defecińska-Trzeciak E
    Przegl Dermatol; 1972; 59(3):315-20. PubMed ID: 4538127
    [No Abstract]   [Full Text] [Related]  

  • 6. Antinucleosome antibodies and systemic lupus erythematosus.
    Düzgün N; Sahin M; Genç Y; Tutkak H
    Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity.
    Mason LJ; Lambrianides A; Haley JD; Manson JJ; Latchman DS; Isenberg DA; Rahman A
    Arthritis Res Ther; 2005; 7(5):R971-83. PubMed ID: 16207338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Antismooth muscle antibody in scleroderma.
    Kitridou RC; Fleischmajer R; Lagosky PA
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081396
    [No Abstract]   [Full Text] [Related]  

  • 9. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.
    Villalta D; Tozzoli R; Bizzaro N; Tonutti E; Ghirardello A; Doria A
    Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sclerodermal and the centromere antibody].
    Ullman S; Rasmussen E; Høier-Madsen M; Wiik A; Halberg P
    Ugeskr Laeger; 1988 Jul; 150(28):1743-6. PubMed ID: 3260421
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic findings in progressive scleroderma--diagnostic and nosologic significance].
    Sönnichsen N; Brenke A; Barthelmes H; Albrecht-Nebe H; Diezel W
    Dermatol Monatsschr; 1983 Jun; 169(6):385-93. PubMed ID: 6603989
    [No Abstract]   [Full Text] [Related]  

  • 12. [Profile of antibodies against nuclear and polynucleotide antigens in diffuse scleroderma].
    Zitnan D; Cebecauer L; Rovenský J; Lukác J
    Cas Lek Cesk; 1982 Nov; 122(45):1392-7. PubMed ID: 6196115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tryptophan metabolism in systemic scleroderma in comparison with immunological phenomena].
    Stachów A; Gliński W; Jarzabek-Chorzelska M
    Przegl Dermatol; 1976; (6 Suppl):357-61. PubMed ID: 1088588
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antinuclear antibodies, complement and circulating immune complexes in scleroderma].
    Cárdenas Ortega A; Mejía Arregui S; Orozco Medina H; Arroyave CM
    Alergia; 1981 Jul; 28(3):111-20. PubMed ID: 7036785
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear antibody profile of progressive systemic sclerosis].
    Dong Y; Chen PZ; Chen M
    Zhonghua Nei Ke Za Zhi; 1987 Mar; 26(3):155-7, 190. PubMed ID: 3497783
    [No Abstract]   [Full Text] [Related]  

  • 16. Roles of nucleosomes in systemic lupus erythematosus: comment on the article by Amoura et al.
    Lee SL
    Arthritis Rheum; 1999 Dec; 42(12):2733-4. PubMed ID: 10616030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Importance of certain laboratory indicators for determination of the activity of systemic scleroderma].
    Shiapak EA; Drampian FS; Kessel' VP; Aznaurian AV; Lobanova IN
    Zh Eksp Klin Med; 1973; 13(3):96-100. PubMed ID: 4599068
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody pattern and other criteria for diagnosis and classification in PSS.
    Burgos-Vargas R; Martínez-Cordero E; Reyes-López PA; Herrera-Esparza R
    J Rheumatol; 1988 Jan; 15(1):153-4. PubMed ID: 3258382
    [No Abstract]   [Full Text] [Related]  

  • 19. Antinuclear antibodies in "healthy" individuals: comment on the article by Tan et al.
    Adebajo AO
    Arthritis Rheum; 1998 Aug; 41(8):1513. PubMed ID: 9704654
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.
    Barnett AJ; McNeilage LJ
    Ann Rheum Dis; 1993 May; 52(5):365-8. PubMed ID: 8323384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.